Baldwin Brothers LLC Gsk PLC Transaction History

Baldwin Brothers LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	BUY	$40.23 - $47.74 $7,844 - $9,309	195 New	195 $8,000
Q4 2021 Jan 14, 2022	SELL	$38.88 - $45.31 $136,429 - $158,992	-3,509 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$38.79 - $43.16 $5,779 - $6,430	149 Added 4.43%	3,509 $134,000
Q2 2021 Jul 30, 2021	SELL	$36.52 - $41.46 $4,966 - $5,638	-136 Reduced 3.89%	3,360 $134,000
Q1 2021 Apr 08, 2021	BUY	$34.27 - $40.01 $2,604 - $3,040	76 Added 2.22%	3,496 $125,000
Q4 2020 Jan 12, 2021	BUY	$34.07 - $39.94 $5,280 - $6,190	155 Added 4.75%	3,420 $126,000
Q3 2020 Oct 16, 2020	BUY	$38.11 - $42.99 $88,415 - $99,736	2,320 Added 245.5%	3,265 $123,000
Q2 2020 Jul 21, 2020	BUY	$37.87 - $43.58 $35,787 - $41,183	945 New	945 $39,000
Q4 2017 Jan 24, 2018	SELL	$35.34 - $41.9 $8,022 - $9,511	-227 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$39.44 - $41.55 $8,952 - $9,431	227	227 $9,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

Stay updated on Baldwin Brothers LLC with notifications on news.